T1	Participants 334 425	125 Swedish primary-care patients with non-acute NSP, full-time sick-listed 6 weeks-2 years
T2	Participants 646 694	2 treatment groups considered as a single cohort
T3	Participants 2145 2185	primary-care patients with non-acute NSP
